Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TALIUS GROUP LIMITED Board/Management Information 2024

Aug 14, 2024

65893_rns_2024-08-14_e372d9f5-ce99-45b8-8fe9-af91cf1c76f2.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [595 x 100] intentionally omitted <==

Talius appoints Dr. Maggie Haertsch as Executive Director

15 August 2024

Talius Group Limited (Talius or the Company ) (ASX: TAL) is pleased to announce the appointment of Dr. Maggie Haertsch to its Board of Directors as an Executive Director, effective immediately.

Dr. Haertsch, a seasoned expert in the aged care industry, has been with Talius since March 2023, serving as the Consulting Clinical Research Director. During her tenure, she has been instrumental in advancing Talius' strategic initiatives, including forging alliances with industry bodies, successfully managing the ARIIA Grant project, and refining the Company's strategy across the residential aged care and home care sectors.

In her new role, Dr. Haertsch will continue to report to Managing Director Graham Russell while expanding her responsibilities within the Board.

With over 40 years of experience in the health and aged care sectors, both in Australia and internationally, Dr. Haertsch brings a wealth of knowledge and a diverse skill set to the Talius Board. Her extensive career spans clinical practice in tertiary teaching hospitals, acute care services, community settings, and low-tech environments, complemented by significant leadership roles in research, education, and executive management.

Dr. Haertsch is exceptionally qualified to contribute to Talius' mission in the aged care sector. She holds a PhD in Behavioral Sciences in Medicine, has completed the Leadership in Digital Transformation in Healthcare program at Harvard Medical School, and possesses a Post-Graduate Diploma in Health Science (Primary Health Care) from the Faculty of Health Sciences from the University of Newcastle. In addition, she is a Registered Nurse and was previously a Registered Midwife.

Commenting on Dr. Haertsch’s appointment, Mr. Graham Russell, Managing Director said: "We are delighted to welcome Dr. Maggie Haertsch to the Board of Directors. Over the past year, Maggie has been a vital part of our senior management team, offering her expertise as a consultant and industry leader. Her contributions have been pivotal in sharpening our focus on the aged care sector, and she will continue to play a key role in client engagement and internal governance, benefiting both our clients and shareholders."

This announcement has been authorised by the Board of Directors of Talius Group Limited.

Investor Enquiries: More on TALIUS
Stephen Rodgers Investor centre
Company Secretary About Us
1300 889 838 News
[email protected]

==> picture [595 x 100] intentionally omitted <==

About Talius Group Limited (ASX: TAL)

Talius provides a suite of technology enabled care solutions to the aged and disability sectors across multiple verticals, including retirement living, residential aged care, home, and community settings to improve the quality of life, later in life.

Talius’ Software as a Service (SaaS) data analytics platform Talius Smart Care combines smart sensors with AI machine learning that delivers automated actions. Talius links awareness, analysis, and action through one platform allowing the care model to move from spot check care to senserespond care. Nursing staff can switch their focus from data collection to building a human connection. Most importantly, residents benefit from a new era of autonomy and dignity.

Talius helps protect and connect our elderly and people with disabilities with a scalable healthcare technology platform integrated with leading third-party providers to ensure end-to-end solutions for Connected Health.

FORWARD LOOKING STATEMENTS

Certain statements contained in this ASX release, including information as to the future financial or operating performance of the Company and its projects, are forward looking statements. Such forward looking statements:

  • (a) are necessarily based upon several estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant technical, business, economic, competitive, political, and social uncertainties and contingencies;

  • (b) involve known and unknown risks and uncertainties that could cause actual events or results to differ materially from estimated or anticipated events or results reflected in such forward looking statements; and

  • (c) may include, among other things, statements regarding estimates and assumptions in respect of prices, costs, results, and capital expenditure, and are or may be based on assumptions and estimates related to future technical, economic, market, political, social, and other conditions. The Company disclaims any intent or obligation to publicly update any forward-looking statements, whether because of new information, future events, or results or otherwise.

The words “believe”, “expect”, "contracted”, “anticipate”, “indicate”, “contemplate”, “target”, “plan”, “intends”, “continue”, “budget”, “estimate”, “may”, “will”, “schedule”, “planned” and similar expressions identify forward looking statements. All forward looking statements contained in this ASX release are qualified by the foregoing cautionary statements. Recipients are cautioned that forward looking statements are not guarantees of future performance and accordingly recipients are cautioned not to put undue reliance on forward looking statements due to the inherent uncertainty therein.

==> picture [595 x 95] intentionally omitted <==

==> picture [595 x 100] intentionally omitted <==

Appendix

Pursuant to the Listing Rule 3.16.4, the Board of Talius Group Limited (ASX: TAL) announces the summary of the key terms of Executive Director, Dr. Maggie Haertsch.

Position Executive Director
Commencement Date 15 August 2024
Term No fixed term. Ongoing until terminated by either party in
accordance with the agreement.
Total Fixed Remuneration $240,000 plus statutory superannuation.
Long Term Incentives The Executive is eligible to participate in any long-term
incentive arrangements operated or introduced by the
Company from time to time, subject to regulatory
approvals and in accordance with the terms and
conditions governing those arrangements and as
separately notified to the Executive by the board.
Termination Either party may terminate the employment by giving no
less than 4 weeks’ notice.

==> picture [595 x 95] intentionally omitted <==